Bryce Point Capital, LLC Bridge Bio Pharma, Inc. Transaction History
Bryce Point Capital, LLC
- $81.9 Billion
- Q3 2025
A detailed history of Bryce Point Capital, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Bryce Point Capital, LLC holds 11,717 shares of BBIO stock, worth $777,891. This represents 0.74% of its overall portfolio holdings.
Number of Shares
11,717
Previous 13,856
15.44%
Holding current value
$777,891
Previous $598 Million
1.72%
% of portfolio
0.74%
Previous 0.51%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
444Shares Held
185MCall Options Held
11.3MPut Options Held
1.84M-
Vanguard Group Inc Valley Forge, PA16.8MShares$1.12 Billion0.01% of portfolio
-
Viking Global Investors LP16MShares$1.06 Billion2.36% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$880 Million27.71% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$826 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X08.74MShares$580 Million0.22% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.84B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...